Justin Hall Nova Bay Pharmaceuticals, Inc. (NBY) insider trading activity
Justin Hall is CEO, GC and Director of NovaBay Pharmaceuticals, Inc.. Currently has a direct ownership of 83,172 shares of NBY, which is worth approximately $49,071. The most recent transaction as insider was on Sep 14, 2022, when has been sold 10,000 shares (Common Stock) at a price of $0.15 per share, resulting in proceeds of $1,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
83.2K
0%
3M change
0%
12M change
Total Value Held
$49,071
Justin Hall Transaction History
JH
Justin Hall
CEO, GC and Director
Emeryville, CA